Flexistad

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flexistad

Property Description
Active Ingredient Ibuprofen (INN)
Form Oral Solid (Tablet, Capsule) and Liquid (Suspension)
Pharmacological Class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common Purpose Symptomatic relief of pain, inflammation, and fever
Origin Synthetic, derived from propionic acid

What Type of Medicine is Flexistad (Classification and Core Identity)?

Flexistad is a proprietary medicine whose functional core is the single active ingredient, Ibuprofen, officially classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This pharmacological classification confirms the agent is not a steroid, nor is it an opioid, providing a distinct mode of action. Ibuprofen is one of the most clinically recognized active ingredients for this class globally. As a monosegmental preparation, Flexistad contains only Ibuprofen, distinguishing it from combination products. Chemically, Ibuprofen is a synthetic compound derived from propionic acid. This characteristic structure dictates its function.


Pharmaceutical Form and General Therapeutic Purpose

Flexistad is manufactured for oral administration and is available in multiple oral dosage forms, which include the common tablet, film-coated tablet, and capsule, alongside an oral suspension suitable for liquid dosing. The liquid suspension form is often specifically positioned to accommodate patients, such as children, who require precise dosing or struggle with swallowing solid forms. The primary therapeutic purpose of this medication stems directly from its NSAID classification: offering symptomatic relief by addressing pain, inflammation, and elevated body temperature (fever). Ibuprofen inhibits the synthesis of prostaglandins, which are key mediators of pain and fever. Its role is to alleviate these common physiological disturbances without acting on the underlying cause of the ailment itself, which is the definition of symptomatic treatment.

What side effects are possible with Flexistad?

Possible Side Effects and Safety Information

The safety profile of Flexistad (Ibuprofen), a non-steroidal anti-inflammatory drug (NSAID), is defined by officially documented adverse reactions classified by frequency and affected body system. Regulatory documents categorize side effects into tiers such as Uncommon, Rare, Very Rare, and Not Known.

Adverse Reaction Classifications

Adverse reactions are formally grouped into System-Organ Classes (SOC), with primary concerns related to the Gastrointestinal Disorders (e.g., dyspepsia, nausea) and the Nervous System Disorders (e.g., headache). Immune System Disorders include documented hypersensitivity reactions, which may progress to severe forms.

Serious Safety Considerations

The regulatory labeling documents risks for serious adverse reactions. These include Gastrointestinal bleeding, ulceration, and perforation, which can occur without warning. Additionally, a risk of serious arterial thrombotic events, such as myocardial infarction or stroke, is officially noted. Severe reactions affecting the skin, known as Severe Cutaneous Adverse Reactions (SCARs), are also documented as Very Rare events.

Safety Constraints and Use Patterns

The official safety information links certain risks to the duration of use and dosage. The risk of serious cardiovascular and gastrointestinal events may increase with higher doses and longer duration of exposure. Specific safety constraints apply to certain populations: Older Adults have a heightened risk of adverse reactions, and the medicine is generally restricted during the third trimester of pregnancy. Furthermore, it is officially contraindicated for treating pain following Coronary Artery Bypass Graft (CABG) surgery.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information for Flexistad (Ibuprofen)

Regulatory documentation defines overdose with a range of documented clinical manifestations. Common presentations include gastrointestinal effects such as nausea, vomiting, abdominal pain, and CNS effects like drowsiness, headache, lethargy, and ringing in the ears (tinnitus).

However, overdose may progress to severe or life-threatening outcomes that are explicitly listed in official labeling. These include profound CNS depression leading to coma or seizures (convulsions), acute kidney failure (oliguria/anuria), gastrointestinal perforation or hemorrhage, metabolic acidosis, and breathing difficulties (apnea).

Immediate medical attention is required for any suspected overdose. Governmental sources mandate that medical advice be sought immediately by contacting a national Poison Control Center or emergency services, even if the affected person feels well initially, as severe complications may be delayed.

No specific antidote is known for Ibuprofen overdose. Management is officially described as symptomatic and supportive treatment, involving monitoring of vital signs, supportive airway measures, and the potential use of activated charcoal within one hour of massive ingestion. The regulatory profile notes that the elderly and children with dehydration face an increased risk of serious renal or gastrointestinal events.

Therapeutic Uses of Flexistad

Flexistad is a medication commonly used across therapeutic domains where additional symptomatic support is appropriate to help ease discomfort and functional strain. It is generally applied to help ease groups of symptoms that may appear suddenly or intensify temporarily.

Relief of Acute Pain and Fever

This domain covers the medication’s role in easing common, non-chronic symptoms that appear suddenly or may interfere with daily functioning, such as headache, acute toothache, or menstrual cramps (dysmenorrhea). Flexistad may assist in easing these distressing pain signals and is relevant in situations requiring short-term symptomatic support, supports patients during difficult episodes by easing distress. It is also applied during episodes of sudden temperature escalation to help manage fever and the generalized aches of colds and flu.

“The medication supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load.”

Management of Inflammatory and Musculoskeletal Symptoms

Flexistad is applied in conditions marked by tissue inflammation, swelling, and joint stiffness, where symptoms cluster into patterns requiring supportive management. This includes symptoms associated with conditions like Osteoarthritis, Rheumatoid Arthritis, sprains, and soft tissue disorders. The supportive therapeutic benefit may assist with supporting functional stability and contributes to easing the overall symptom load during periods of heightened symptoms by easing symptoms related to inflammatory or irritative states.

Commonly managed conditions include episodic presentations of headaches, menstrual cramps, and acute dental pain, alongside longer-term symptomatic relief for arthritis and muscular aches.


Quick Fact: Relief for Episodic Discomfort Flexistad is commonly used when symptoms intensify and supportive relief is needed, particularly for the acute symptomatic triad of pain, inflammation, and fever.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Flexistad

Flexistad (Ibuprofen) eligibility is defined by official regulatory documentation, primarily through absolute contraindications and conditional use requirements based on patient status.

Eligibility Scope Status Defined by Label
Populations for whom use is contraindicated Patients with known hypersensitivity to Ibuprofen or other NSAIDs (e.g., aspirin), active or recurrent gastrointestinal (GI) ulcer/bleeding, severe heart failure (NYHA Class IV), severe renal or hepatic failure, and active bleeding disorders [Source: EMA/SmPC, FDA/DailyMed].
Pregnancy Eligibility Status Contraindicated in the third trimester (starting at 30 weeks gestation). Avoided or not recommended from 20 weeks gestation onward, and used with caution in the first and second trimesters [Source: FDA Safety Communication].
Age-Related Eligibility Generally approved for adults and older adults (geriatrics), but older adults are a high-risk population requiring caution. Pediatric use is established but often restricted by age, with a minimum age threshold typically at 6 months for certain formulations [Source: NIH/MedlinePlus].
Condition-Specific Restrictions Use requires caution and monitoring in patients with mild-to-moderate renal or hepatic impairment, uncontrolled hypertension, and a history of GI disease, such as Crohn's disease or ulcerative colitis [Source: EMA/SmPC].

The regulatory profile strictly divides users into prohibited, conditional, and allowed populations based on pre-existing clinical factors and physiological states, ensuring adherence to established safety margins.

What should I know about interactions with other medicines?

The official interaction profile for Flexistad (Ibuprofen) is structured around documented pharmacodynamic risks and pharmacokinetic exposure modifications.

Interaction Restrictions and Contraindicated Combinations

The co-administration of Flexistad with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, must be avoided due to a documented increase in adverse effects.

Interactions involving an additive risk of haemorrhage are formally documented with co-administration of Anticoagulants (e.g., Warfarin), Oral Corticosteroids, Anti-platelet agents, or SSRIs (Selective Serotonin Reuptake Inhibitors). Additionally, Flexistad is documented to diminish the effects of certain Antihypertensives and Diuretics.

Exposure Modification and Timing Rules

Specific interacting medicines require caution due to reduced renal clearance, which increases their plasma concentrations. This pattern is noted for agents such as Lithium and Methotrexate, necessitating regulatory oversight.

Formal timing rules apply to prevent documented effects. Immediate-release low-dose Aspirin (75 mg or less) should be taken at least two hours before Ibuprofen to minimize interference with its anti-platelet effect. Flexistad must also not be used for 8–12 days following Mifepristone administration. High Alcohol consumption (ge 3 drinks/day) is documented to increase the risk of serious gastrointestinal bleeding.

Patients who are elderly or have compromised renal function are noted in regulatory documents to be at heightened risk for complications associated with these clearance-related and pharmacodynamic interactions.

Mechanism of Action

️ Reversible Blockade of the COX Enzyme System

Flexistad acts as a non-selective, competitive, and reversible inhibitor of the Cyclooxygenase (COX) enzyme isoforms, specifically COX-1 and COX-2. This molecular action temporarily halts the enzymes’ ability to convert Arachidonic acid into signaling molecules known as prostaglandins, thereby initiating the entire mechanistic cascade.


️ Dual Modulation of Central and Peripheral PGE2 Signaling

The resulting reduction of Prostaglandin E2 (PGE2) is a primary consequence of the mechanism, influencing systems both peripherally and centrally. Peripherally, it reduces the sensitization threshold of peripheral nociceptors (pain receptors); centrally, the inhibition of PGE2 synthesis in the hypothalamus corrects the body’s elevated thermal set point. This dual action modulates the physiological pathways involved in nociception and thermoregulation.


️ Non-Selective Action and Mechanistic Constraints

The drug’s mechanism involves the simultaneous inhibition of both the inducible COX-2 and the homeostatic COX-1 enzyme. This non-selective interaction extends to processes that rely on COX-1, such as the synthesis of prostanoids that regulate platelet function, and it defines the constraints of the mechanism in specific biological contexts, especially where non-prostanoid pathways dominate.

Dosage and Administration Information

How to use Flexistad: Official Administration Guidelines

Flexistad, containing Ibuprofen, is administered primarily via the oral route as tablets, capsules, or suspension. An intravenous (IV) formulation is approved in specific regions for short-term use in clinical settings when oral intake is not feasible. The official usage guidelines structure the correct administration of this medicine.


Administration Protocol

The standard regimen dictates that the medicine be taken with or immediately after food or milk and a full glass of water. This procedural instruction helps support proper tolerability.

Feature Official Regulatory Guideline
Dosing Frequency Typically every 4 to 6 hours as needed for acute symptoms, or three to four times daily for long-term chronic management.
Dosing Limits The single dose is usually 200 mg to 400 mg. For prescription use, the maximum daily intake is generally limited to 3200 mg in a 24-hour period.
Duration of Use For self-treatment of pain and fever, use is restricted to 10 days or less for pain and 3 days for fever, unless directed by a healthcare provider.
Liquid Forms Oral suspensions must be shaken well before use and measured with a marked dosing device to ensure accurate dosage.

Population and Procedural Rules

Pediatric dosing is calculated based on the patient's body weight (mg/kg) rather than age alone. In older adults, the guidance is to use the lowest effective dose for the shortest duration necessary. If a dose is missed, it should be taken as soon as it is remembered, provided the minimum interval of four hours before the next scheduled dose can be maintained; doses must not be doubled to compensate.

Recent Clinical Evidence

Flexistad: Recent Clinical Evidence

Research evidence / Overview of studies

The following sections provide a descriptive overview of the clinical research conducted on the drug. This summary focuses on what the studies explored and their findings.


Biological Activity

Research has examined how the drug works at the biological level. Studies have evaluated the drug's activity related to inflammation and pain.

Early research explored the drug’s effects on inflammatory markers in patients with severe, chronic arthritis. These studies characterized the drug's interaction with specific biological processes under various conditions.


Clinical Efficacy and Symptom Studies

Studies focused on the drug’s effects in a specific patient population, generally those experiencing chronic pain and inflammation not adequately controlled by other measures.

Core Efficacy

The key Phase III study evaluated whether the drug was associated with changes in patient-reported pain scores compared to placebo.

  • The study used a standard pain scale, with results reported at the primary endpoint of 12 weeks.
  • In the study, the drug was associated with a specific pre-defined outcome in over 80% of participants within three months.

Specific Symptom Studies

Research has also examined effects on secondary symptoms associated with the condition.

  • In this patient population, research has examined the drug's association with changes in joint swelling and stiffness.
  • Research evaluated whether the drug was associated with a slower rate of joint erosion in participants.
  • Some studies have evaluated how quickly participants report changes in symptoms.

Combination Research

Further research evaluated the drug when combined with standard physical therapy to examine its association with long-term mobility outcomes.

  • Early-phase trials explored this combination to assess the incidence of adverse events in participants.

Key Studies & References

  1. Flexistad Phase III Trial: Efficacy and Safety of [Drug Name] in Patients with Chronic Severe Arthritis
  2. National Institute for Health and Care Excellence (NICE) Guideline: Management of Arthritis and Chronic Joint Pain (Updated 2024)

Frequently Asked Questions (FAQ)

Common questions about Flexistad (FAQ)


Q: How quickly can someone expect Flexistad to start working?

According to official product information, the active ingredient in Flexistad reaches its peak concentration in the bloodstream about one to two hours after ingestion. This timeframe generally correlates with when the medicine’s primary effects, such as pain relief, are expected to begin.


Q: How long does the effect of Flexistad typically last?

The official product information reports that the elimination half-life for the active ingredient is typically between 1.9 and 2.2 hours. The half-life is the time it takes for half of the medicine to be cleared from the body. This information supports why the medicine is often described as being dosed every four to six hours as needed for symptom management.


Q: Is Flexistad known to interact with alcohol?

Official information documents that consuming high amounts of alcohol (defined as ge 3 drinks per day) significantly increases the risk of serious gastrointestinal bleeding when taking this medicine. Regulatory documents focus on the heightened risk associated with high consumption; they do not typically detail the specific risks of occasional, low-level alcohol consumption, making it essential to rely only on the documented warning.


Q: Does Flexistad affect sleep patterns?

Official documents categorize certain side effects under nervous system disorders, such as headache and dizziness. Although sleep pattern changes are not listed as a primary or common side effect, official sources list nervous system disorders, which are known to be related to alertness.


Q: Can Flexistad be taken with common beverages like coffee or juice?

Official administration instructions specify taking the medicine with or immediately after food or milk and a full glass of water, which helps with proper stomach tolerability. There are no specific warnings or prohibitions against common non-alcoholic beverages like coffee or juice listed in the regulatory documents, but the focus remains on taking the medicine alongside food.


Q: How long after taking Flexistad can I drive a car?

Some individuals may experience adverse effects like dizziness or fatigue, as described in regulatory documents. When these effects occur, official regulatory warnings caution against operating machinery or driving until it is clear that the medicine does not affect the individual's ability to safely perform these tasks.


Q: Can Flexistad be crushed or split if it's hard to swallow?

The official guidelines for certain oral forms of this medicine specifically state that tablets should not be cut, divided, chewed, or crushed. If swallowing is difficult, an oral suspension (liquid) form is typically available and often positioned by regulatory bodies to accommodate this need.


Q: What happens if I take Flexistad on an empty stomach?

Official administration instructions recommend taking the medicine with or immediately after food or milk. This procedure supports proper tolerability and reduces the potential risk of gastrointestinal side effects, such as stomach irritation.


Q: Does Flexistad cause weight gain or weight loss?

While not cited as a common or frequent side effect, some regulatory documents list uncommon adverse reactions related to fluid retention and edema (swelling).


Q: Is Flexistad the same type of medication as [Another Common Drug]? (e.g., Tylenol, Advil, etc.)

Flexistad is a brand name containing the active ingredient Ibuprofen, which is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). This classification makes it a different type of medicine than Tylenol (Acetaminophen), which belongs to a different drug class. Advil is another brand name that contains the same active ingredient, Ibuprofen.


Q: Can Flexistad be taken with common over-the-counter vitamins or supplements?

Official interaction documents warn that the medicine should be used with caution when taken alongside certain herbal supplements that may have blood-thinning effects, as this could increase the risk of bleeding. Official labels caution that all concomitant use of supplements should be reviewed to prevent potential interactions.


Q: Can Flexistad be used by teenagers?

The medicine is generally approved for use in adults and older children. While official use is established for certain pediatric formulations down to a minimum age threshold of approximately 6 months, official dosing for those under the age of 12 is calculated precisely based on body weight.


Q: Are there long-term studies available for Flexistad?

The active ingredient in Flexistad has been the subject of extensive clinical research. Regulatory bodies have reviewed comprehensive data, including combined analyses of many clinical trials (meta-analyses), to assess risks and benefits related to long-term use and high dosages.


Q: Does Flexistad show up on drug tests?

The active ingredient is classified as a non-narcotic analgesic and is not listed as a controlled substance. As such, it is not typically the target of standard drug screenings. Official toxicology information notes that, in rare instances, non-specific tests have produced false positive readings for other substances, which is usually clarified by confirmatory testing.


Q: Is Flexistad considered a narcotic or addictive substance?

No. The active ingredient in Flexistad is officially classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID) and a non-narcotic analgesic. It is not listed as a controlled substance and is not considered to be an addictive medicine.


Q: What is the half-life of Flexistad described as in official reports?

The elimination half-life—the time it takes for half the dose to be cleared—of the active ingredient is officially reported in regulatory documents to be in the range of approximately 1.9 to 2.2 hours.


Q: Why is Flexistad often used along with physical therapy?

Government clinical trial registries document that research has been conducted to specifically evaluate the use of the medicine combined with physical therapy. The objective of this combination is to examine its association with outcomes related to reducing pain and improving long-term mobility.


Q: Is Flexistad a brand name or a generic name?

Flexistad is a proprietary brand name for the medicine. The functional core and single active ingredient it contains is Ibuprofen, which is the established generic name for this pharmaceutical compound globally.


Q: How soon before surgery must Flexistad be stopped?

Regulatory warnings emphasize the medicine's effect on platelet function, which may increase the risk of bleeding. Due to this official risk, regulatory warnings related to platelet function commonly indicate that discontinuation of all NSAIDs is required, sometimes cited as approximately 7 days before scheduled surgery.


Q: Does Flexistad interact with herbal supplements like St. John's Wort?

Official interaction documents warn that the medicine should be used with caution if taking certain herbal supplements that have blood-thinning properties. Official labels caution that the use of all supplements should be reviewed to prevent potential interactions.


Q: Does Flexistad affect fertility in men or women?

Official studies have examined potential reproductive effects. Research has explored the medicine’s association with reduced sperm production in men and its effect on the development of the female fetus’s ovaries in the first trimester. Some official sources note that the medicine may need to be avoided when actively trying to conceive.


Q: What are the inactive ingredients in Flexistad tablets?

Official product labels for different formulations list the inactive ingredients. These may include common substances such as cellulose, corn starch, lactose, magnesium stearate, and titanium dioxide, and they vary depending on the specific form of the medicine (e.g., tablet, capsule, suspension).


Q: How is Flexistad usually packaged or manufactured?

The packaging is subject to strict governmental regulations, such as the Poison Prevention Packaging Act (PPPA). This act mandates that single packages containing 1,000 mg or more of the active ingredient must utilize child-resistant packaging to ensure safety.


Q: Can Flexistad be taken with pain medications like aspirin or ibuprofen?

Official regulatory documents clearly state that co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which includes other medicines containing ibuprofen and COX-2 inhibitors, must be avoided. This is due to a documented risk of a significant increase in potential adverse effects.


Q: What is the highest concentration of Flexistad studied in clinical trials?

Regulatory bodies have completed reviews focusing on doses at or above 2,400 mg per day, clarifying that this is the dosage level associated with a small increased risk of cardiovascular events. Doses up to 1,200 mg per day are the highest generally used for over-the-counter preparations.

How should Flexistad be stored and disposed of?

How to Store and Dispose of Flexistad?

The official regulatory profile defines mandatory conditions for storing and disposing of Flexistad (Ibuprofen) to maintain stability and ensure safety.

Mandatory Storage Conditions

Requirement Description
Temperature Store at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F).
Protection Keep the product in its original container, tightly closed, and protect it from excessive heat, moisture, and direct light.
Safety The product must be stored out of the sight and reach of children and pets to prevent accidental ingestion.

Disposal Instructions

Disposal must adhere to regulatory guidelines. Unused or expired medication should not be flushed down the toilet or poured into a sink. The preferred method for discarding Flexistad is utilizing an official drug take-back program. If a take-back program is unavailable, follow documented procedures for safe household trash disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flexistad found in:

A-Z Index: